| MWF/FubRkb |
tibia length |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
tibia length |
male |
113.0 days
| 10 |
4.2 |
cm |
1.0 |
3.16 |
post excision length measurement |
|
0.0 |
|
109397 |
3140 |
| MWF/FubRkb |
mesenteric artery media thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114.0 days
| 10 |
19.6 |
um |
0.7 |
2.21 |
confocal microscopy |
|
0.0 |
|
109429 |
3140 |
| MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasodilation trait |
male |
114.0 days
| 10 |
82.3 |
% |
3.0 |
9.49 |
wire myography |
mesenteric artery |
0.0 |
|
109433 |
3140 |
| MWF/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114.0 days
| 10 |
77.8 |
% |
10.2 |
32.26 |
wire myography |
|
0.0 |
|
109441 |
3140 |
| MWF/FubRkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114.0 days
| 10 |
6.9 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
|
109445 |
3140 |
| MWF/FubRkb |
body weight |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
body mass |
male |
112.0 days
| 10 |
362.8 |
g |
12.8 |
40.48 |
body weighing method |
|
0.0 |
|
109389 |
3140 |
| MWF/FubRkb |
timed urine volume |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine output |
male |
114.0 days
| 10 |
10.1 |
ml/d |
0.4 |
1.26 |
metabolic cage urine volume measurement method |
|
0.0 |
|
109401 |
3140 |
| MWF/FubRkb |
mesenteric artery adventitial thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114.0 days
| 10 |
8.6 |
um |
0.7 |
2.21 |
confocal microscopy |
|
0.0 |
|
109425 |
3140 |
| MWF/FubRkb |
pulse wave velocity |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112.0 days
| 10 |
5.6 |
/ms |
0.5 |
1.58 |
tail cuff plethysmography |
|
0.0 |
|
109417 |
3140 |
| MWF/FubRkb |
urine albumin excretion rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114.0 days
| 10 |
64.4 |
mg/d |
5.6 |
17.71 |
enzyme linked immunosorbent assay |
|
0.0 |
|
109405 |
3140 |
| MWF/FubRkb |
systolic blood pressure |
vehicle control condition (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112.0 days
| 10 |
151.5 |
mmHg |
9.0 |
28.46 |
tail cuff plethysmography |
|
0.0 |
|
109409 |
3140 |
| MWF/FubRkb |
heart rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
heart pumping trait |
male |
112.0 days
| 10 |
352.3 |
beats/min |
7.3 |
23.08 |
tail cuff plethysmography |
heart |
0.0 |
|
109413 |
3140 |
| MWF/FubRkb |
mesenteric artery wall thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114.0 days
| 10 |
36.3 |
um |
1.1 |
3.48 |
confocal microscopy |
|
0.0 |
|
109421 |
3140 |